Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients. Issue 5 (May 2019)
- Record Type:
- Journal Article
- Title:
- Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients. Issue 5 (May 2019)
- Main Title:
- Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients
- Authors:
- Oswald, Nicola
Halle-Smith, James
Kerr, Amy
Webb, Joanne
Agostini, Paula
Bishay, Ehab
Kalkat, Maninder
Steyn, Richard
Naidu, Babu - Abstract:
- Abstract: Background: Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially modifiable factors associated with these events. Methods: Prospective cohort study at a United Kingdom tertiary referral centre conducted over 55 months. Binary logistic regression was used to identify factors associated with death within 90 days of surgery. Results: The 30 day and 90 day mortality rates were 1.4% and 3.3% respectively. The most common causes of death were pneumonia, lung cancer and Acute Respiratory Distress Syndrome/Multi Organ Failure. Potentially modifiable risk factors for death identified were: Postoperative pulmonary complications (Odds ratio 6.1), preoperative lymphocyte count (OR 0.25), readmission within 30 days (OR 4.2) and type of postoperative analgesia (OR for intrathecal morphine 4.8). The most common causes of readmission were pneumonia, shortness of breath and pain. Conclusions: Postoperative mortality is not simply due to fixed factors; the impacts of age, gender and surgical procedure on postoperative survival are reduced when the postoperative course of recovery is examined. Perioperative immune function, as portrayed by the occurrence of infection and lower lymphocyte count in the immediate perioperative period, and painAbstract: Background: Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially modifiable factors associated with these events. Methods: Prospective cohort study at a United Kingdom tertiary referral centre conducted over 55 months. Binary logistic regression was used to identify factors associated with death within 90 days of surgery. Results: The 30 day and 90 day mortality rates were 1.4% and 3.3% respectively. The most common causes of death were pneumonia, lung cancer and Acute Respiratory Distress Syndrome/Multi Organ Failure. Potentially modifiable risk factors for death identified were: Postoperative pulmonary complications (Odds ratio 6.1), preoperative lymphocyte count (OR 0.25), readmission within 30 days (OR 4.2) and type of postoperative analgesia (OR for intrathecal morphine 4.8). The most common causes of readmission were pneumonia, shortness of breath and pain. Conclusions: Postoperative mortality is not simply due to fixed factors; the impacts of age, gender and surgical procedure on postoperative survival are reduced when the postoperative course of recovery is examined. Perioperative immune function, as portrayed by the occurrence of infection and lower lymphocyte count in the immediate perioperative period, and pain control method are strongly associated with 90 day mortality; further studies in these fields are indicated as are studies of psychological factors in recovery. Clinical registration number: ISRCTN00061628. … (more)
- Is Part Of:
- European journal of surgical oncology. Volume 45:Issue 5(2019)
- Journal:
- European journal of surgical oncology
- Issue:
- Volume 45:Issue 5(2019)
- Issue Display:
- Volume 45, Issue 5 (2019)
- Year:
- 2019
- Volume:
- 45
- Issue:
- 5
- Issue Sort Value:
- 2019-0045-0005-0000
- Page Start:
- 863
- Page End:
- 869
- Publication Date:
- 2019-05
- Subjects:
- Lung cancer -- Thoracic surgery -- Outcomes -- Mortality -- Readmission
Oncology -- Periodicals
Cancer -- Surgery -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Cancérologie -- Périodiques
Oncologie
Chirurgie (geneeskunde)
Electronic journals
Electronic journals -- Sciences
Electronic journals -- Medicine
Electronic journals
616.994059005 - Journal URLs:
- http://www.ejso.com/ ↗
http://www.sciencedirect.com/science/journal/07487983 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/07487983 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0720048X ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0748-7983;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗
http://www.harcourt-international.com/journals ↗
http://www.idealibrary.com/cgi-bin/links/toc/ejso ↗ - DOI:
- 10.1016/j.ejso.2019.02.001 ↗
- Languages:
- English
- ISSNs:
- 0748-7983
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.745500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9809.xml